Grow Your Wealth
with Mutual Funds
Tata India Pharma & Healthcare Fund Direct-idcw
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 1,455.2 Cr.
NAV as on 03 aug, 2026
₹ 38.81
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Tata India Pharma & Healthcare Fund Direct-idcw
Inception Date
28 Dec 2015
Lock In
No Lock-in
SIP Minimum Investment amount
₹100
SWP Minimum Investment amount
₹500
STP Minimum Investment amount
₹500
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
97.42%
Cash
2.58%
Portfolio Updated on: 10 Jul, 2026
Sector Allocations
Equity
Healthcare
Materials
Financial
Consumer Staples
Industrials
Portfolio Updated on: 03 aug, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.87% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.38% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.94% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.03% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.59% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.59% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.66% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.51% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.51% |
Debt & Credit Risk Analysis
| Alpha | -1.35% |
| Beta | 0.99% |
| R2 | 0.97% |
| Sharpe Ratio | 0.91% |
| Standard Deviation | 16.38% |
| Sortino Ratio | 1.37% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 13.56% | NA | 6.12% |
| 6 Months | 17.94% | NA | 12.92% |
| 9 Months | 10.30% | NA | 4.47% |
| 1 Year | 12.58% | 12.58% | 6.04% |
| 2 Years | 19.86% | 9.48% | 24.93% |
| 3 Years | 77.42% | 21.06% | 25.71% |
| 5 Years | 103.42% | 15.26% | 19.91% |
| 7 Years | 333.50% | 23.31% | NA |
| 10 Years | 301.05% | 14.90% | 12.78% |
Tata India Pharma & Healthcare Fund Direct-idcw is one Equity mutual fund offered by Tata Mutual Fund. Launched on 28 Dec 2015, the fund aims Long Term Capital Appreciation. Investment in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India. It manages assets worth ₹1,455.2 crore as on Tue Jun 30, 2026. The expense ratio stands at 1.02%.
Rajat Srivastava has experience Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,997.7 | +2.81% | +17.48% | +25.25% | +20.07% | +24.60% | +17.98% |
| SBI Healthcare Opportunities Fund-growth | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| SBI Healthcare Opportunities Fund-idcw | 4,997.7 | +2.72% | +17.19% | +24.63% | +18.87% | +23.32% | +16.75% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,624.6 | +0.97% | +10.20% | +15.47% | +10.98% | +24.03% | +16.63% |
| DSP Healthcare Fund Direct-growth | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| DSP Healthcare Fund Direct-idcw | 3,514.0 | +2.43% | +13.63% | +18.99% | +10.81% | +21.00% | +15.99% |
| Mirae Asset Healthcare Fund Direct-growth | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
| Mirae Asset Healthcare Fund Direct-idcw | 3,252.5 | +3.07% | +14.10% | +24.01% | +19.66% | +23.87% | +15.83% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Tata Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular-growth | 1,455.2 | +3.57% | +13.15% | +17.12% | +10.97% | +19.30% | +13.57% |
| Tata India Pharma & Healthcare Fund Direct-growth | 1,455.2 | +3.69% | +13.56% | +17.94% | +12.58% | +21.06% | +15.26% |
| Tata India Pharma & Healthcare Fund Regular-idcw | 1,455.2 | +3.57% | +13.15% | +17.12% | +10.97% | +19.30% | +13.57% |
| Tata Nifty Midsmall Healthcare Index Fund Regular-growth | 182.2 | +1.76% | +14.99% | +22.80% | +15.35% | — | — |
| Tata Nifty Midsmall Healthcare Index Fund Direct-growth | 182.2 | +1.81% | +15.17% | +23.17% | +16.05% | — | — |
| Tata Nifty Midsmall Healthcare Index Fund Regular-idcw | 182.2 | +1.76% | +14.99% | +22.80% | +15.35% | — | — |
| Tata Nifty Midsmall Healthcare Index Fund Direct-idcw | 182.2 | +1.81% | +15.17% | +23.17% | +16.05% | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹595.67 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹413.85 | +24.60% | +17.98% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹514.75 | +23.32% | +16.75% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹324.27 | +23.32% | +16.75% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.77 | +24.03% | +16.63% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.85 | +24.03% | +16.63% | — |
| Dsp Healthcare Fund Direct-growth | ₹49.33 | +21.00% | +15.99% | — |
| Dsp Healthcare Fund Direct-idcw | ₹28.53 | +21.00% | +15.99% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹51.65 | +23.87% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹31.11 | +23.87% | +15.83% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 03 Aug 2026 | ₹38.81 |
| 31 Jul 2026 | ₹38.50 |
| 30 Jul 2026 | ₹38.46 |
| 29 Jul 2026 | ₹38.52 |
| 28 Jul 2026 | ₹38.15 |
| 27 Jul 2026 | ₹38.12 |
| 24 Jul 2026 | ₹37.64 |
| 23 Jul 2026 | ₹37.71 |
| 22 Jul 2026 | ₹37.91 |
| 21 Jul 2026 | ₹38.16 |
| 20 Jul 2026 | ₹38.02 |
| 17 Jul 2026 | ₹37.70 |
| 16 Jul 2026 | ₹38.05 |
| 15 Jul 2026 | ₹37.94 |
| 14 Jul 2026 | ₹37.87 |
| 13 Jul 2026 | ₹37.67 |
| 10 Jul 2026 | ₹37.63 |
| 09 Jul 2026 | ₹37.41 |
| 08 Jul 2026 | ₹36.90 |
| 07 Jul 2026 | ₹37.28 |
| 06 Jul 2026 | ₹37.56 |
| 03 Jul 2026 | ₹37.43 |
| 02 Jul 2026 | ₹37.06 |
| 01 Jul 2026 | ₹36.88 |
| 30 Jun 2026 | ₹36.88 |
| 29 Jun 2026 | ₹36.55 |
| 25 Jun 2026 | ₹36.51 |
| 24 Jun 2026 | ₹36.60 |
| 23 Jun 2026 | ₹36.49 |
| 22 Jun 2026 | ₹36.47 |
Portfolio Updated on: 04 Aug, 2026
Fund Growth & Size Analysis
+₹1,455.2 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Tata India Pharma & Healthcare Fund Direct-idcw Returns Comparison
Compare Tata India Pharma & Healthcare Fund Direct-idcw with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Tata India Pharma & He....
No funds found for your search.
Tata India Pharma & Healthcare Fund Direct-idcw FAQ'S
- Sharpe Ratio: 0.91%
- Standard Deviation: 16.38%
- Beta: 0.99%
- Alpha: -1.35%
- R-squared: 0.97%
- Information Ratio: -0.54%
- Sortino Ratio: 1.37%
Additional important ratios:
As of Tue Jun 30, 2026, the total assets managed under Tata India Pharma & Healthcare Fund Direct-idcw stand at approximately ₹ 1,455.2 crore.
The Tata India Pharma & Healthcare Fund Direct-idcw has delivered the following short-term performance:
- 3 Months Return: 13.56%
- 6 Months Return: 17.94%
The historical growth of the Tata India Pharma & Healthcare Fund Direct-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 21.06%
- 5 Year CAGR: 15.26%
- Return Since Launch: 13.99%
The portfolio of Tata India Pharma & Healthcare Fund Direct-idcw is distributed across different asset classes as follows:
- Equity: 97.42%
- Other Assets: 2.58%
The Tata India Pharma & Healthcare Fund Direct-idcw is managed by Rajat Srivastava, representing Tata Mutual Fund.
The Tata India Pharma & Healthcare Fund Direct-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 24.67%
- Mid Cap Stocks: 34.76%
- Small Cap Stocks: 40.58%
Top stock holdings of Tata India Pharma & Healthcare Fund Direct-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 9.87% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.38% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.94% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.03% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.59% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.59% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.34% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 9.66% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.51% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 8.51% of the portfolio
Major sector exposures in Tata India Pharma & Healthcare Fund Direct-idcw are:
- Healthcare – accounts for 1,215.90% of the portfolio
- Materials – accounts for 45.43% of the portfolio
- Financial – accounts for 4.83% of the portfolio
- Consumer Staples – accounts for 3.81% of the portfolio
- Industrials – accounts for 0.27% of the portfolio
